New pill aims to shorten COPD Flare-Ups from common cold
Symptom relief
Recruiting now
This study tests an oral drug called vapendavir in 180 adults with COPD who catch a rhinovirus (common cold). The goal is to see if it can reduce the severity and length of breathing symptoms compared to a placebo. Participants are randomly assigned to one of two doses or a place…
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC